Surya Kant Tripathi

1.6k total citations
34 papers, 784 citations indexed

About

Surya Kant Tripathi is a scholar working on Molecular Biology, Materials Chemistry and Cancer Research. According to data from OpenAlex, Surya Kant Tripathi has authored 34 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Materials Chemistry and 5 papers in Cancer Research. Recurrent topics in Surya Kant Tripathi's work include Nanoparticles: synthesis and applications (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and MicroRNA in disease regulation (4 papers). Surya Kant Tripathi is often cited by papers focused on Nanoparticles: synthesis and applications (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and MicroRNA in disease regulation (4 papers). Surya Kant Tripathi collaborates with scholars based in India, United States and South Korea. Surya Kant Tripathi's co-authors include Bijesh Kumar Biswal, Munmun Panda, Kannan R. R. Rengasamy, Kamal Pandey, Gökhan Zengin, Ajit Prakash, Atif Khurshid Wani, Nahid Akhtar, Hari Prasad Devkota and A. C. JAIN and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and Food and Chemical Toxicology.

In The Last Decade

Surya Kant Tripathi

31 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Surya Kant Tripathi India 15 374 144 137 122 101 34 784
Bijesh Kumar Biswal India 18 541 1.4× 162 1.1× 150 1.1× 140 1.1× 144 1.4× 49 966
Claire M. Pfeffer United States 5 755 2.0× 175 1.2× 63 0.5× 190 1.6× 176 1.7× 5 1.3k
Dilip M. Mondhe India 20 535 1.4× 185 1.3× 52 0.4× 117 1.0× 69 0.7× 30 1.1k
Yiqun Xia China 17 509 1.4× 108 0.8× 69 0.5× 75 0.6× 112 1.1× 25 771
Marie-Hélène Teiten Luxembourg 14 426 1.1× 116 0.8× 54 0.4× 81 0.7× 59 0.6× 15 859
Shakti Prasad Pattanayak India 19 395 1.1× 153 1.1× 39 0.3× 108 0.9× 85 0.8× 57 1.0k
Malek Zihlif Jordan 15 297 0.8× 120 0.8× 39 0.3× 125 1.0× 101 1.0× 78 742
Avinaba Mukherjee India 16 352 0.9× 90 0.6× 31 0.2× 125 1.0× 102 1.0× 40 872
Fangfang Yang China 19 408 1.1× 189 1.3× 36 0.3× 166 1.4× 103 1.0× 25 974
Katarzyna Wiktorska Poland 16 393 1.1× 202 1.4× 59 0.4× 94 0.8× 42 0.4× 43 702

Countries citing papers authored by Surya Kant Tripathi

Since Specialization
Citations

This map shows the geographic impact of Surya Kant Tripathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surya Kant Tripathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surya Kant Tripathi more than expected).

Fields of papers citing papers by Surya Kant Tripathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surya Kant Tripathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surya Kant Tripathi. The network helps show where Surya Kant Tripathi may publish in the future.

Co-authorship network of co-authors of Surya Kant Tripathi

This figure shows the co-authorship network connecting the top 25 collaborators of Surya Kant Tripathi. A scholar is included among the top collaborators of Surya Kant Tripathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surya Kant Tripathi. Surya Kant Tripathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Surbhi, et al.. (2024). Current and future therapeutic approaches of CFTR and airway dysbiosis in an era of personalized medicine. SHILAP Revista de lepidopterología. 13(6). 2200–2208. 1 indexed citations
2.
Tripathi, Surya Kant, et al.. (2024). Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(8). 5631–5647. 4 indexed citations
3.
Wani, Atif Khurshid, Nahid Akhtar, Tahir ul Gani Mir, et al.. (2023). Targeting Apoptotic Pathway of Cancer Cells with Phytochemicals and Plant-Based Nanomaterials. Biomolecules. 13(2). 194–194. 84 indexed citations
4.
Panda, Munmun, et al.. (2023). Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer. Archives of Oral Biology. 151. 105697–105697. 13 indexed citations
5.
Tripathi, Surya Kant, et al.. (2022). SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance. Drug Discovery Today. 27(9). 2541–2550. 17 indexed citations
6.
Akhtar, Nahid, Atif Khurshid Wani, Surya Kant Tripathi, Ajit Prakash, & M. Amin‐ul Mannan. (2022). The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review. Current Research in Biotechnology. 4. 337–349. 8 indexed citations
7.
Gupta, Piyush Kumar, Surya Kant Tripathi, Rekha Gahtori, et al.. (2021). Anticancer therapeutic efficacy of biogenic Am-ZnO nanoparticles on 2D and 3D tumor models. Materials Today Chemistry. 22. 100618–100618. 40 indexed citations
8.
Gupta, Piyush Kumar, Rekha Gahtori, Surya Kant Tripathi, et al.. (2021). Phytomedicines Targeting Cancer Stem Cells: Therapeutic Opportunities and Prospects for Pharmaceutical Development. Pharmaceuticals. 14(7). 676–676. 13 indexed citations
9.
Tripathi, Surya Kant & Bijesh Kumar Biswal. (2021). Allosteric mutant-selective fourth-generation EGFR inhibitors as an efficient combination therapeutic in the treatment of non-small cell lung carcinoma. Drug Discovery Today. 26(6). 1466–1472. 26 indexed citations
10.
Pathak, Pankaj, Jitendra Singh, Monika Agarwal, Vivek Singh, & Surya Kant Tripathi. (2021). Study to assess the home-based newborn care (HBNC) visit in rural area of Lucknow. SHILAP Revista de lepidopterología. 10(4). 1673–1677. 5 indexed citations
11.
Tripathi, Surya Kant, Kannan R. R. Rengasamy, & Bijesh Kumar Biswal. (2020). Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction. Archives of Pharmacal Research. 43(2). 242–256. 54 indexed citations
12.
Pandey, Kamal, Surya Kant Tripathi, Munmun Panda, & Bijesh Kumar Biswal. (2020). Prooxidative activity of plumbagin induces apoptosis in human pancreatic ductal adenocarcinoma cells via intrinsic apoptotic pathway. Toxicology in Vitro. 65. 104788–104788. 22 indexed citations
13.
Tripathi, Surya Kant & Bijesh Kumar Biswal. (2020). Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent. Pharmacological Research. 156. 104772–104772. 108 indexed citations
14.
Tripathi, Surya Kant, Munmun Panda, & Bijesh Kumar Biswal. (2019). Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy. Food and Chemical Toxicology. 125. 566–582. 103 indexed citations
15.
Gupta, Piyush Kumar, Surya Kant Tripathi, Sreenath Pappuru, et al.. (2019). Metal-free semi-aromatic polyester as nanodrug carrier: A novel tumor targeting drug delivery vehicle for potential clinical application. Materials Science and Engineering C. 107. 110285–110285. 26 indexed citations
16.
Tripathi, Surya Kant, Kamal Pandey, Munmun Panda, et al.. (2019). The potential of retinoids for combination therapy of lung cancer: Updates and future directions. Pharmacological Research. 147. 104331–104331. 21 indexed citations
17.
Tripathi, Surya Kant, et al.. (2019). A green approach towards formulation, characterization, and antimicrobial activity of poly (Lactic-co-Glycolic) acid-Alstonia scholaris based nanoparticle. Materials Research Express. 6(9). 95325–95325. 4 indexed citations
18.
Biswal, Bijesh Kumar & Surya Kant Tripathi. (2017). Wnt/b-Catenin: The Main Culprit behind Cancer Chemoresistance. 1(4). 2 indexed citations
19.
Tripathi, Surya Kant, et al.. (2014). Posterior mediastinal mass diagnosed as schwanomma with concomittant tuberculosis. BMJ Case Reports. 2014. bcr2014205799–bcr2014205799. 1 indexed citations
20.
Rubin, David T., et al.. (1998). The return of Sarasvati : four Hindi poets. Oxford University Press eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026